Related Experiment Videos
[Depression in cancer patients]
1Department für Psychiatrie und Psychotherapie, Medizinische Universität Innsbruck, Anichstrasse 35, 6020, Innsbruck, Österreich, barbara.sperner-unterweger@i-med.ac.at.
Wiener Medizinische Wochenschrift (1946)
|July 5, 2015
Summary
Cancer patients frequently experience depression, impacting their quality of life and prognosis. Early recognition and adequate therapy for cancer-related depression are crucial for improved outcomes and reduced suicide risk.
Area of Science:
- Oncology
- Psychiatry
- Clinical Medicine
Context:
- Depression is a common comorbidity in cancer patients, affecting up to 60% of individuals.
- Depressive symptoms can manifest at any point during cancer care, with increased risk post-diagnosis.
- Underdiagnosis and undertreatment of depression in cancer patients are significant challenges, with oncologists identifying depression in only 15-50% of cases.
Purpose:
- To highlight the prevalence and impact of depression in cancer patients.
- To underscore the diagnostic challenges and low rates of adequate therapy for cancer-related depression.
- To emphasize the critical need for improved management of depression to enhance patient outcomes.
Summary:
- Cancer patients frequently experience major depression or depressive syndromes, significantly impacting their quality of life.
- Underrecognition by oncologists (15-50%) and inadequate therapy rates contribute to poor patient outcomes, including impaired treatment adherence and increased suicide risk.
- Despite limited clinical trials, effective psychotherapeutic and pharmacological interventions for depression in cancer patients are available.
Impact:
- Improved recognition and treatment of depression can enhance cancer patients' quality of life.
- Effective management of depression may improve treatment compliance and overall cancer prognosis.
- Addressing depression in cancer care is vital for reducing suicide rates and improving patient survival.
Related Concept Videos
01:21Cancer Survival Analysis
838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
02:49Cancer Therapies
10.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.7K
02:49Cancer Therapies
3.0K
3.0K
01:19Psychoneuroimmunology: Diabetes and Cancer
639
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
639
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
01:18Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K